Nox1 in cardiovascular diseases: Regulation and pathophysiology

Clinical Science

Volumn 130, Issue 3, 2016, Pages 151-165

  Gimenez, Marcela ^a,b   Schickling, Brandon M ^a   Lopes, Lucia R ^b   Miller, Francis J ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell signalling; NADPH oxidase; Oxidative stress; Reactive oxygen species; Vascular disease

Indexed keywords

2 (2 CHLOROPHENYL) 4 [3 (DIMETHYLAMINO)PHENYL] 5 METHYL 1H PYRAZOLO[4,3 C]PYRIDINE 3,6(2H,5H) DIONE; ANGIOTENSIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; NITRIC OXIDE; PAXILLIN; PROSTAGLANDIN F2 ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SUPEROXIDE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; ISOENZYME; NOX1 PROTEIN, HUMAN;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HYPERTENSION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPERFUSION INJURY; RESTENOSIS; REVIEW; SEQUENCE HOMOLOGY; ANIMAL; CARDIOVASCULAR DISEASES; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; MOLECULAR TARGETED THERAPY; NADPH OXIDASE;

EID: 84951913287     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150404     Document Type: Review

References (150)

1. Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A.B., Griendling, K.K. and Lambeth, J.D. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82
2. Lassegue, B., San Martin, A. and Griendling, K.K. (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110, 1364-1390
3. Kawahara, T., Quinn, M. and Lambeth, J.D. (2007) Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol. Biol. 7, 109
4. Banfi, B., Maturana, A., Jaconi, S., Arnaudeau, S., Laforge, T., Sinha, B., Ligeti, E., Demaurex, N. and Krause, K.H. (2000) A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287, 138-142
5. Geiszt, M., Lekstrom, K. and Leto, T.L. (2004) Analysis of mRNA transcripts from the NAD(P)H oxidase 1 (Nox1) gene. Evidence against production of the NADPH oxidase homolog-1 short (NOH-1S) transcript variant. J. Biol. Chem. 279, 51661-51668
6. Harper, R.W., Xu, C., Soucek, K., Setiadi, H. and Eiserich, J.P. (2005) A reappraisal of the genomic organization of human Nox1 and its splice variants. Arch. Biochem. Biophys. 435, 323-330
7. Arakawa, N., Katsuyama, M., Matsuno, K., Urao, N., Tabuchi, Y., Okigaki, M., Matsubara, H. and Yabe-Nishimura, C. (2006) Novel transcripts of Nox1 are regulated by alternative promoters and expressed under phenotypic modulation of vascular smooth muscle cells. Biochem. J. 398, 303-310
8. Banfi, B., Clark, R.A., Steger, K. and Krause, K.H. (2003) Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278, 3510-3513
9. Gianni, D., Diaz, B., Taulet, N., Fowler, B., Courtneidge, S.A. and Bokoch, G.M. (2009) Novel p47(phox)-related organizers regulate localized NADPH oxidase 1 (Nox1) activity. Sci. Signal. 2, ra54
10. Gianni, D., DerMardirossian, C. and Bokoch, G.M. (2011) Direct interaction between Tks proteins and the N-terminal proline-rich region (PRR) of NoxA1 mediates Nox1-dependent ROS generation. Eur. J. Cell Biol. 90, 164-171
11. Takeya, R., Ueno, N., Kami, K., Taura, M., Kohjima, M., Izaki, T., Nunoi, H. and Sumimoto, H. (2003) Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J. Biol. Chem. 278, 25234-25246
12. Ago, T., Nunoi, H., Ito, T. and Sumimoto, H. (1999) Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J. Biol. Chem. 274, 33644-33653
13. Faust, L.R., el Benna, J., Babior, B.M. and Chanock, S.J. (1995) The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis. J. Clin. Invest. 96, 1499-1505
14. Yamamoto, A., Kami, K., Takeya, R. and Sumimoto, H. (2007) Interaction between the SH3 domains and C-terminal proline-rich region in NADPH oxidase organizer 1 (Noxo1). Biochem. Biophys. Res. Commun. 352, 560-565
15. Yamamoto, A., Takeya, R., Matsumoto, M., Nakayama, K.I. and Sumimoto, H. (2013) Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1. FEBS J. 280, 5145-5159
16. Koga, H., Terasawa, H., Nunoi, H., Takeshige, K., Inagaki, F. and Sumimoto, H. (1999) Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J. Biol. Chem. 274, 25051-25060
17. Geiszt, M., Lekstrom, K., Witta, J. and Leto, T.L. (2003) Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J. Biol. Chem. 278, 20006-20012
18. Miller, Jr, F.J., Chu, X., Stanic, B., Tian, X., Sharma, R.V., Davisson, R.L. and Lamb, F.S. (2010) A differential role for endocytosis in receptor-mediated activation of Nox1. Antioxid. Redox Signal. 12, 583-593
19. Miller, Jr, F.J., Filali, M., Huss, G.J., Stanic, B., Chamseddine, A., Barna, T.J. and Lamb, F.S. (2007) Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ. Res. 101, 663-671
20. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S.L., Lambeth, J.D. and Griendling, K.K. (2001) Novel gp91 phox homologues in vascular smooth muscle cells. nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88, 888-894
21. Vendrov, A.E., Madamanchi, N.R., Niu, X.L., Molnar, K.C., Runge, M., Szyndralewiez, C., Page, P. and Runge, M.S. (2010) NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J. Biol. Chem. 285, 26545-26557
22. Matsuno, K., Iwata, K., Matsumoto, M., Katsuyama, M., Cui, W., Murata, A., Nakamura, H., Ibi, M., Ikami, K., Zhang, J. et al. (2012) NOX1/NADPH oxidase is involved in endotoxin-induced cardiomyocyte apoptosis. Free Radic. Biol. Med. 53, 1718-1728
23. Honjo, T., Otsui, K., Shiraki, R., Kawashima, S., Sawamura, T., Yokoyama, M. and Inoue, N. (2008) Essential role of NOXA1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells. Endothelium 15, 137-141
24. Lee, M.Y., Martin, A.S., Mehta, P.K., Dikalova, A.E., Garrido, A.M., Datla, S.R., Lyons, E., Krause, K.-H., Banfi, B., Lambeth, J.D. et al. (2009) Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler. Thromb. Vasc. Biol. 29, 480-487
25. Schroder, K., Helmcke, I., Palfi, K., Krause, K.H., Busse, R. and Brandes, R.P. (2007) Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 27, 1736-1743
26. Lu, X., Dang, C.Q., Guo, X., Molloi, S., Wassall, C.D., Kemple, M.D. and Kassab, G.S. (2011) Elevated oxidative stress and endothelial dysfunction in right coronary artery of right ventricular hypertrophy. J. Appl. Physiol. 110, 1674-1681
27. Sorescu, G.P., Song, H., Tressel, S.L., Hwang, J., Dikalov, S., Smith, D.A., Boyd, N.L., Platt, M.O., Lassegue, B., Griendling, K.K. and Jo, H. (2004) Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ. Res. 95, 773-779
28. Wilkinson-Berka, J.L., Deliyanti, D., Rana, I., Miller, A.G., Agrotis, A., Armani, R., Szyndralewiez, C., Wingler, K., Touyz, R.M. and Cooper, M.E. (2014) NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy. Antioxid. Redox Signal. 20, 2726-2740
29. Braunersreuther, V., Montecucco, F., Ashri, M., Pelli, G., Galan, K., Frias, M., Burger, F., Quindere, A.L., Montessuit, C., Krause, K.H. et al. (2013) Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 64, 99-107
30. Cevik, M.O., Katsuyama, M., Kanda, S., Kaneko, T., Iwata, K., Ibi, M., Matsuno, K., Kakehi, T., Cui, W., Sasaki, M. and Yabe-Nishimura, C. (2008) The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: possible involvement of the ERK1/2-JunB pathway. Biochem. Biophys. Res. Commun. 374, 351-355
31. Katsuyama, M., Ozgur Cevik, M., Arakawa, N., Kakehi, T., Nishinaka, T., Iwata, K., Ibi, M., Matsuno, K. and Yabe-Nishimura, C. (2007) Myocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme. FEBS J. 274, 5128-5136
32. Manea, A., Tanase, L.I., Raicu, M. and Simionescu, M. (2010) Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 396, 901-907
33. Katsuyama, M., Fan, C., Arakawa, N., Nishinaka, T., Miyagishi, M., Taira, K. and Yabe-Nishimura, C. (2005) Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem. J. 386, 255-261
34. Manea, S.A., Todirita, A., Raicu, M. and Manea, A. (2014) C/EBP transcription factors regulate NADPH oxidase in human aortic smooth muscle cells. J. Cell. Mol. Med. 18, 1467-1477
35. Manea, A., Tanase, L.I., Raicu, M. and Simionescu, M. (2010) Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 30, 105-112
36. Brewer, A.C., Sparks, E.C. and Shah, A.M. (2006) Transcriptional regulation of the NADPH oxidase isoform, Nox1, in colon epithelial cells: role of GATA-binding factor(s). Free Radic. Biol. Med. 40, 260-274
37. Stanic, B., Katsuyama, M. and Miller, Jr, F.J. (2010) An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler. Thromb. Vasc. Biol. 30, 2234-2241
38. Huang, J. and Kleinberg, M.E. (1999) Activation of the phagocyte NADPH oxidase protein p47(phox). Phosphorylation controls SH3 domain-dependent binding to p22(phox). J. Biol. Chem. 274, 19731-19737
39. Maehara, Y., Miyano, K., Yuzawa, S., Akimoto, R., Takeya, R. and Sumimoto, H. (2010) A conserved region between the TPR and activation domains of p67phox participates in activation of the phagocyte NADPH oxidase. J. Biol. Chem. 285, 31435-31445
40. Ago, T., Kuribayashi, F., Hiroaki, H., Takeya, R., Ito, T., Kohda, D. and Sumimoto, H. (2003) Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc. Natl. Acad. Sci. U.S.A. 100, 4474-4479
41. el Benna, J., Faust, L.P. and Babior, B.M. (1994) The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J. Biol. Chem. 269, 23431-23436
42. Dang, P.M., Raad, H., Derkawi, R.A., Boussetta, T., Paclet, M.H., Belambri, S.A., Makni-Maalej, K., Kroviarski, Y., Morel, F., Gougerot-Pocidalo, M.A. and El-Benna, J. (2011) The NADPH oxidase cytosolic component p67phox is constitutively phosphorylated in human neutrophils: regulation by a protein tyrosine kinase, MEK1/2 and phosphatases 1/2A. Biochem. Pharmacol. 82, 1145-1152
43. Lewis, E.M., Sergeant, S., Ledford, B., Stull, N., Dinauer, M.C. and McPhail, L.C. (2010) Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding. J. Biol. Chem. 285, 2959-2967
44. Regier, D.S., Greene, D.G., Sergeant, S., Jesaitis, A.J. and McPhail, L.C. (2000) Phosphorylation of p22phox is mediated by phospholipase D-dependent and-independent mechanisms. Correlation of NADPH oxidase activity and p22phox phosphorylation. J. Biol. Chem. 275, 28406-28412
45. Benna, J.E., Dang, P.M., Gaudry, M., Fay, M., Morel, F., Hakim, J. and Gougerot-Pocidalo, M.A. (1997) Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J. Biol. Chem. 272, 17204-17208
46. Fontayne, A., Dang, P.M., Gougerot-Pocidalo, M.A. and El-Benna, J. (2002) Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41, 7743-7750
47. El Benna, J., Han, J., Park, J.W., Schmid, E., Ulevitch, R.J. and Babior, B.M. (1996) Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. Arch. Biochem. Biophys. 334, 395-400
48. Touyz, R.M., Yao, G. and Schiffrin, E.L. (2003) c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23, 981-987
49. Chowdhury, A.K., Watkins, T., Parinandi, N.L., Saatian, B., Kleinberg, M.E., Usatyuk, P.V. and Natarajan, V. (2005) Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells. J. Biol. Chem. 280, 20700-20711
50. Dang, P.M., Morel, F., Gougerot-Pocidalo, M.A. and El Benna, J. (2003) Phosphorylation of the NADPH oxidase component p67(PHOX) by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region. Biochemistry 42, 4520-4526
51. Forbes, L.V., Truong, O., Wientjes, F.B., Moss, S.J. and Segal, A.W. (1999) The major phosphorylation site of the NADPH oxidase component p67phox is Thr233. Biochem. J. 338, 99-105
52. Debbabi, M., Kroviarski, Y., Bournier, O., Gougerot-Pocidalo, M.A., El-Benna, J. and Dang, P.M. (2013) NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation. FASEB J. 27, 1733-1748
53. Kroviarski, Y., Debbabi, M., Bachoual, R., Perianin, A., Gougerot-Pocidalo, M.A., El-Benna, J. and Dang, P.M. (2010) Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J. 24, 2077-2092
54. Kim, J.S., Diebold, B.A., Babior, B.M., Knaus, U.G. and Bokoch, G.M. (2007) Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3-3 binding. J. Biol. Chem. 282, 34787-34800
55. Streeter, J., Schickling, B.M., Jiang, S., Stanic, B., Thiel, W.H., Gakhar, L., Houtman, J.C. and Miller, Jr, F.J. (2014) Phosphorylation of Nox1 regulates association with NoxA1 activation domain. Circ. Res. 115, 911-918
56. Pandey, D., Chen, F., Patel, A., Wang, C.Y., Dimitropoulou, C., Patel, V.S., Rudic, R.D., Stepp, D.W. and Fulton, D.J. (2011) SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases. Arterioscler. Thromb. Vasc. Biol. 31, 1634-1642
57. Matsumoto, M., Katsuyama, M., Iwata, K., Ibi, M., Zhang, J., Zhu, K., Nauseef, W.M. and Yabe-Nishimura, C. (2014) Characterization of N-glycosylation sites on the extracellular domain of NOX1/NADPH oxidase. Free Radic. Biol. Med. 68, 196-204
58. Miyano, K. and Sumimoto, H. (2014) N-Linked glycosylation of the superoxide-producing NADPH oxidase Nox1. Biochem. Biophys. Res. Commun. 443, 1060-1065
59. Laurindo, F.R., Araujo, T.L. and Abrahao, T.B. (2014) Nox NADPH oxidases and the endoplasmic reticulum. Antioxid. Redox Signal. 20, 2755-2775
60. Hilenski, L.L., Clempus, R.E., Quinn, M.T., Lambeth, J.D. and Griendling, K.K. (2004) Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24, 677-683
61. Chen, F., Barman, S., Yu, Y., Haigh, S., Wang, Y., Dou, H., Bagi, Z., Han, W., Su, Y. and Fulton, D.J. (2014) Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species. Free Radic. Biol. Med. 73, 201-213
62. Chen, F., Yu, Y., Qian, J., Wang, Y., Cheng, B., Dimitropoulou, C., Patel, V., Chadli, A., Rudic, R.D., Stepp, D.W. et al. (2012) Opposing actions of heat shock protein 90 and 70 regulate nicotinamide adenine dinucleotide phosphate oxidase stability and reactive oxygen species production. Arterioscler. Thromb. Vasc. Biol. 32, 2989-2999
63. Fernandes, D.C., Manoel, A.H., Wosniak, Jr, J. and Laurindo, F.R. (2009) Protein disulfide isomerase overexpression in vascular smooth muscle cells induces spontaneous preemptive NADPH oxidase activation and Nox1 mRNA expression: effects of nitrosothiol exposure. Arch. Biochem. Biophys. 484, 197-204
64. Pescatore, L.A., Bonatto, D., Forti, F.L., Sadok, A., Kovacic, H. and Laurindo, F.R. (2012) Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation. J. Biol. Chem. 287, 29290-29300
65. Janiszewski, M., Lopes, L.R., Carmo, A.O., Pedro, M.A., Brandes, R.P., Santos, C.X. and Laurindo, F.R. (2005) Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J. Biol. Chem. 280, 40813-40819
66. Camargo Lde, L., Babelova, A., Mieth, A., Weigert, A., Mooz, J., Rajalingam, K., Heide, H., Wittig, I., Lopes, L.R. and Brandes, R.P. (2013) Endo-PDI is required for TNFalpha-induced angiogenesis. Free Radic. Biol. Med. 65, 1398-1407
67. de, A.P.A.M., Verissimo-Filho, S., Guimaraes, L.L., Silva, A.C., Takiuti, J.T., Santos, C.X., Janiszewski, M., Laurindo, F.R. and Lopes, L.R. (2011) Protein disulfide isomerase redox-dependent association with p47(phox): evidence for an organizer role in leukocyte NADPH oxidase activation. J. Leukoc. Biol. 90, 799-810
68. Chen, W., Shang, W.H., Adachi, Y., Hirose, K., Ferrari, D.M. and Kamata, T. (2008) A possible biochemical link between NADPH oxidase (Nox) 1 redox-signalling and ERp72. Biochem. J. 416, 55-63
69. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624
70. Dikalova, A.E., Gongora, M.C., Harrison, D.G., Lambeth, J.D., Dikalov, S. and Griendling, K.K. (2010) Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 299, H673-H679
71. Youn, J.Y., Gao, L. and Cai, H. (2012) The p47phox-and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia 55, 2069-2079
72. Zou, M.H., Shi, C. and Cohen, R.A. (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109, 817-826
73. Sydow, K. and Munzel, T. (2003) ADMA and oxidative stress. Atheroscler. Suppl. 4, 41-51
74. Fan, C., Katsuyama, M., Nishinaka, T. and Yabe-Nishimura, C. (2005) Transactivation of the EGF receptor and a PI3 kinase-ATF-1 pathway is involved in the upregulation of NOX1, a catalytic subunit of NADPH oxidase. FEBS Lett. 579, 1301-1305
75. Jagadeesha, D.K., Takapoo, M., Banfi, B., Bhalla, R.C. and Miller, Jr, F.J. (2012) Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration. Cardiovasc. Res. 93, 406-413
76. Haloui, M., Meilhac, O., Jandrot-Perrus, M. and Michel, J.B. (2003) Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin. Eur. J. Pharmacol. 474, 175-184
77. Jiang, S., Streeter, J., Schickling, B.M., Zimmerman, K., Weiss, R.M. and Miller, Jr, F.J. (2014) Nox1 NADPH oxidase is necessary for late but not early myocardial ischaemic preconditioning. Cardiovasc. Res. 102, 79-87
78. Selemidis, S., Seow, H.J., Broughton, B.R., Vinh, A., Bozinovski, S., Sobey, C.G., Drummond, G.R. and Vlahos, R. (2013) Nox1 oxidase suppresses influenza a virus-induced lung inflammation and oxidative stress. PLoS One 8, e60792
79. Whitmore, L.C., Hilkin, B.M., Goss, K.L., Wahle, E.M., Colaizy, T.T., Boggiatto, P.M., Varga, S.M., Miller, F.J. and Moreland, J.G. (2013) NOX2 protects against prolonged inflammation, lung injury, and mortality following systemic insults. J. Innate Immun. 5, 565-580
80. Szocs, K., Lassegue, B., Sorescu, D., Hilenski, L.L., Valppu, L., Couse, T.L., Wilcox, J.N., Quinn, M.T., Lambeth, J.D. and Griendling, K.K. (2002) Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 22, 21-27
81. Xu, S., Shriver, A.S., Jagadeesha, D.K., Chamseddine, A., Szocs, K., Weintraub, N.L., Griendling, K.K., Bhalla, R. and Miller, Jr, F.J. (2012) Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9. J. Vasc. Res. 49, 242-248
82. Lee, J.H., Joo, J.H., Kim, J., Lim, H.J., Kim, S., Curtiss, L., Seong, J.K., Cui, W., Yabe-Nishimura, C. and Bae, Y.S. (2013) Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells. Cardiovasc. Res. 99, 483-493
83. Valente, A.J., Yoshida, T., Murthy, S.N., Sakamuri, S.S., Katsuyama, M., Clark, R.A., Delafontaine, P. and Chandrasekar, B. (2012) Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Am. J. Physiol. Heart Circ. Physiol. 303, H282-H296
84. Bruder-Nascimento, T., Chinnasamy, P., Riascos-Bernal, D.F., Cau, S.B., Callera, G.E., Touyz, R.M., Tostes, R.C. and Sibinga, N.E. (2014) Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. J. Mol. Cell. Cardiol. 66, 18-26
85. Ushio-Fukai, M. (2006) Localizing NADPH oxidase-derived ROS. Sci. STKE 2006, re8
86. Zimmerman, M.C., Takapoo, M., Jagadeesha, D.K., Stanic, B., Banfi, B., Bhalla, R.C. and Miller, F.J. (2011) Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells. Hypertension 58, 446-453
87. Sheehan, A.L., Carrell, S., Johnson, B., Stanic, B., Banfi, B. and Miller, Jr, F.J. (2011) Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 216, 321-326
88. Menshikov, M., Plekhanova, O., Cai, H., Chalupsky, K., Parfyonova, Y., Bashtrikov, P., Tkachuk, V. and Berk, B.C. (2006) Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways. Arterioscler. Thromb. Vasc. Biol. 26, 801-807
89. Wang, X. and Sun, Z. (2010) Thyroid hormone induces artery smooth muscle cell proliferation: discovery of a new TRalpha1-Nox1 pathway. J. Cell. Mol. Med. 14, 368-380
90. Gavazzi, G., Banfi, B., Deffert, C., Fiette, L., Schappi, M., Herrmann, F. and Krause, K.H. (2006) Decreased blood pressure in NOX1-deficient mice. FEBS Lett. 580, 497-504
91. Iwata, K., Ikami, K., Matsuno, K., Yamashita, T., Shiba, D., Ibi, M., Matsumoto, M., Katsuyama, M., Cui, W., Zhang, J. et al. (2014) Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 34, 110-119
92. Arbiser, J.L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E.R., Brown, L.F., Cohen, C., Moses, M., Kilroy, S., Arnold, R.S. and Lambeth, J.D. (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. U.S.A. 99, 715-720
93. Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L. et al. (2011) Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARalpha mediated mechanism. PLoS One 6, e14665
94. Guzik, T.J., Sadowski, J., Guzik, B., Jopek, A., Kapelak, B., Przybylowski, P., Wierzbicki, K., Korbut, R., Harrison, D.G. and Channon, K.M. (2006) Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 26, 333-339
95. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., Valppu, L., Quinn, M.T., Lambeth, J.D., Vega, J.D. et al. (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105, 1429-1435
96. Azumi, H., Inoue, N., Takeshita, S., Rikitake, Y., Kawashima, S., Hayashi, Y., Itoh, H. and Yokoyama, M. (1999) Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 100, 1494-1498
97. Guzik, T.J., West, N.E., Black, E., McDonald, D., Ratnatunga, C., Pillai, R. and Channon, K.M. (2000) Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ. Res. 86, E85-E90
98. Madrigal-Matute, J., Fernandez-Garcia, C.E., Gomez-Guerrero, C., Lopez-Franco, O., Munoz-Garcia, B., Egido, J., Blanco-Colio, L.M. and Martin-Ventura, J.L. (2012) HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. Cardiovasc. Res. 95, 116-123
99. Stanic, B., Pandey, D., Fulton, D.J. and Miller, Jr, F.J. (2012) Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 2452-2460
100. Niu, X.L., Madamanchi, N.R., Vendrov, A.E., Tchivilev, I., Rojas, M., Madamanchi, C., Brandes, R.P., Krause, K.H., Humphries, J., Smith, A. et al. (2010) Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation 121, 549-559
101. Xu, S., Chamseddine, A.H., Carrell, S. and Miller, Jr, F.J. (2014) Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques. Redox Biol. 2, 642-650
102. Sobey, C.G., Judkins, C.P., Rivera, J., Lewis, C.V., Diep, H., Lee, H.W., Kemp-Harper, B.K., Broughton, B.R., Selemidis, S., Gaspari, T.A. et al. (2015) NOX1 deficiency in apolipoprotein E-knockout mice is associated with elevated plasma lipids and enhanced atherosclerosis. Free Radic. Res. 49, 186-198
103. Gray, S.P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A.C., de Haan, J.B., Koulis, C., El-Osta, A., Andrews, K.L. et al. (2013) NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127, 1888-1902
104. Konior, A., Schramm, A., Czesnikiewicz-Guzik, M. and Guzik, T.J. (2014) NADPH oxidases in vascular pathology. Antioxid. Redox Signal. 20, 2794-2814
105. Briones, A.M., Tabet, F., Callera, G.E., Montezano, A.C., Yogi, A., He, Y., Quinn, M.T., Salaices, M. and Touyz, R.M. (2011) Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J. Am. Soc. Hypertens. 5, 137-153
106. Wind, S., Beuerlein, K., Armitage, M.E., Taye, A., Kumar, A.H., Janowitz, D., Neff, C., Shah, A.M., Wingler, K. and Schmidt, H.H. (2010) Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56, 490-497
107. Androwiki, A.C., Camargo Lde, L., Sartoretto, S., Couto, G.K., Ribeiro, I.M., Verissimo-Filho, S., Rossoni, L.V. and Lopes, L.R. (2015) Protein disulfide isomerase expression increases in resistance arteries during hypertension development. Effects on Nox1 NADPH oxidase signaling. Front. Chem. 3, 24
108. Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H. and Yabe-Nishimura, C. (2005) Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112, 2677-2685
109. Yogi, A., Mercure, C., Touyz, J., Callera, G.E., Montezano, A.C., Aranha, A.B., Tostes, R.C., Reudelhuber, T. and Touyz, R.M. (2008) Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 51, 500-506
110. Dikalova, A., Clempus, R., Lassegue, B., Cheng, G., McCoy, J., Dikalov, S., San Martin, A., Lyle, A., Weber, D.S., Weiss, D. et al. (2005) Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112, 2668-2676
111. Peterson, J.R., Burmeister, M.A., Tian, X., Zhou, Y., Guruju, M.R., Stupinski, J.A., Sharma, R.V. and Davisson, R.L. (2009) Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain Angiotensin II. Hypertension 54, 1106-1114
112. Veit, F., Pak, O., Egemnazarov, B., Roth, M., Kosanovic, D., Seimetz, M., Sommer, N., Ghofrani, H.A., Seeger, W., Grimminger, F. et al. (2013) Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling. Antioxid. Redox Signal. 19, 2213-2231
113. Kahles, T. and Brandes, R.P. (2013) Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2. Antioxid. Redox Signal. 18, 1400-1417
114. Choi, D.H., Kim, J.H., Lee, K.H., Kim, H.Y., Kim, Y.S., Choi, W.S. and Lee, J. (2015) Role of neuronal NADPH oxidase 1 in the peri-infarct regions after stroke. PLoS One 10, e0116814
115. Kahles, T., Kohnen, A., Heumueller, S., Rappert, A., Bechmann, I., Liebner, S., Wittko, I.M., Neumann-Haefelin, T., Steinmetz, H., Schroeder, K. and Brandes, R.P. (2010) NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice. Neurobiol. Dis. 40, 185-192
116. Jackman, K.A., Miller, A.A., Drummond, G.R. and Sobey, C.G. (2009) Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Brain Res. 1286, 215-220
117. Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M.E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P. et al. (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 8, e1000479
118. Komatsu, D., Kato, M., Nakayama, J., Miyagawa, S. and Kamata, T. (2008) NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 27, 4724-4732
119. Ushio-Fukai, M. (2007) VEGF signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signal. 9, 731-739
120. Kamata, T. (2009) Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci. 100, 1382-1388
121. Rey, F.E., Cifuentes, M.E., Kiarash, A., Quinn, M.T. and Pagano, P.J. (2001) Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2-and systolic blood pressure in mice. Circ. Res. 89, 408-414
122. Dahan, I., Issaeva, I., Gorzalczany, Y., Sigal, N., Hirshberg, M. and Pick, E. (2002) Mapping of functional domains in the p22(phox) subunit of flavocytochrome b(559) participating in the assembly of the NADPH oxidase complex by "peptide walking". J. Biol. Chem. 277, 8421-8432
123. Park, M.Y., Imajoh-Ohmi, S., Nunoi, H. and Kanegasaki, S. (1994) Peptides corresponding to the region adjacent to His-94 in the small subunit of cytochrome b558 inhibit superoxide generation in a cell-free system from human neutrophils. Biochem. Biophys. Res. Commun. 204, 924-929
124. Nauseef, W.M., McCormick, S., Clark, R.A., Renee, J. and Leidal, K.G. (1993) Functional domain in an arginine-rich carboy terminal region of p47/phox. J. Biol. Chem. 268, 23646-23651
125. DeLeo, F.R., Nauseef, W.M., Jesaitis, A.J., Burritt, J.B., Clark, R.A. and Quinn, M.T. (1995) A domain of p47phox that interacts with human neutrophil flavocytochrome b558. J. Biol. Chem. 270, 26246-26251
126. Labadia, M.E., Zu, Y.L. and Huang, C.K. (1996) A synthetic peptide containing a predominant protein kinase C site within p47phox inhibits the NADPH oxidase in intact neutrophils. J. Leukoc. Biol. 59, 116-124
127. Weaver, M., Liu, J., Pimentel, D., Reddy, D.J., Harding, P., Peterson, E.L. and Pagano, P.J. (2006) Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery. Am. J. Physiol. Heart Circ. Physiol. 290, H1933-H1941
128. Joseph, G., Gorzalczany, Y., Koshkin, V. and Pick, E. (1994) Inhibition of NADPH oxidase activation by synthetic peptides mapping within the carboxyl-terminal domain of small GTP-binding proteins. Lack of amino acid sequence specificity and importance of polybasic motif. J. Biol. Chem. 269, 29024-29031
129. Kreck, M.L., Uhlinger, D.J., Tyagi, S.R., Inge, K.L. and Lambeth, J.D. (1994) Participation of the small molecular weight GTP-binding protein Rac1 in cell-free activation and assembly of the respiratory burst oxidase. Inhibition by a carboxyl-terminal Rac peptide. J. Biol. Chem. 269, 4161-4168
130. Dahan, I. and Pick, E. (2012) Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides". Cell. Mol. Life Sci. 69, 2283-2305
131. Kim, J.A., Neupane, G.P., Lee, E.S., Jeong, B.S., Park, B.C. and Thapa, P. (2011) NADPH oxidase inhibitors: a patent review. Expert Opin. Ther. Pat. 21, 1147-1158
132. Di Marco, E., Gray, S.P., Chew, P., Koulis, C., Ziegler, A., Szyndralewiez, C., Touyz, R.M., Schmidt, H.H., Cooper, M.E., Slattery, R. and Jandeleit-Dahm, K.A. (2014) Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice. Diabetologia 57, 633-642
133. Schürmann, C., Rezende, F., Kruse, C., Yasar, Y., Lowe, O., Fork, C., van de Sluis, B., Bremer, R., Weissmann, N., Shah, A.M. et al. (2015) The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur. Heart J., doi:10.1093/eurheartj/ehv460
134. Bruder-Nascimento, T., Callera, G.E., Montezano, A.C., He, Y., Antunes, T.T., Cat, A.N., Tostes, R.C. and Touyz, R.M. (2015) Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways. Clin. Sci. 128, 411-423
135. Streeter, J., Thiel, W., Brieger, K. and Miller, Jr, F.J. (2013) Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease. Cardiovasc. Ther. 31, 125-137
136. Tanaka, S., Fukumoto, Y., Nochioka, K., Minami, T., Kudo, S., Shiba, N., Takai, Y., Williams, C.L., Liao, J.K. and Shimokawa, H. (2013) Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler. Thromb. Vasc. Biol. 33, 1591-1600
137. Brandes, R.P., Weissmann, N. and Schroder, K. (2014) Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases. J. Mol. Cell. Cardiol. 73, 70-79
138. Drummond, G.R. and Sobey, C.G. (2014) Endothelial NADPH oxidases: which NOX to target in vascular disease? Trends Endocrinol. Metab. 25, 452-463
139. Judkins, C.P., Diep, H., Broughton, B.R., Mast, A.E., Hooker, E.U., Miller, A.A., Selemidis, S., Dusting, G.J., Sobey, C.G. and Drummond, G.R. (2010) Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/-mice. Am. J. Physiol. Heart Circ. Physiol. 298, H24-H32
140. Barry-Lane, P.A., Patterson, C., van der Merwe, M., Hu, Z.Y., Holland, S.M., Yeh, E.T.H. and Runge, M.S. (2001) p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 108, 1513-1522
141. Schmidt, H.H., Wingler, K., Kleinschnitz, C. and Dusting, G. (2012) NOX4 is a Janus-faced reactive oxygen species generating NADPH oxidase. Circ. Res. 111, e15-e16
142. Moreland, J.G., Davis, A.P., Matsuda, J.J., Hook, J.S., Bailey, G., Nauseef, W.M. and Lamb, F.S. (2007) Endotoxin priming of neutrophils requires NADPH oxidase-generated oxidants and is regulated by the anion transporter ClC-3. J. Biol. Chem. 282, 33958-33967
143. Basset, O., Deffert, C., Foti, M., Bedard, K., Jaquet, V., Ogier-Denis, E. and Krause, K.H. (2009) NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II-receptor localization in vascular smooth muscle. Antioxid. Redox Signal. 11, 2371-2384
144. Tiyerili, V., Becher, U.M., Aksoy, A., Lutjohann, D., Wassmann, S., Nickenig, G. and Mueller, C.F. (2013) AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARgamma. Cardiovasc. Diabetol. 12, 30
145. Shihabi, A., Li, W.G., Miller, Jr, F.J. and Weintraub, N.L. (2002) Antioxidant therapy for atherosclerotic vascular disease: the promise and the pitfalls. Am. J. Physiol. Heart Circ. Physiol. 282, H797-H802
146. Craige, S.M., Chen, K., Pei, Y., Li, C., Huang, X., Chen, C., Shibata, R., Sato, K., Walsh, K. and Keaney, Jr, J.F. (2011) NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124, 731-740
147. Ray, R., Murdoch, C.E., Wang, M., Santos, C.X., Zhang, M., Alom-Ruiz, S., Anilkumar, N., Ouattara, A., Cave, A.C., Walker, S.J. et al. (2011) Endothelial nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 31, 1368-1376
148. Rezende, F., Lowe, O., Helfinger, V., Prior, K.K., Walter, M., Zukunft, S., Fleming, I., Weissmann, N., Brandes, R.P. and Schroder, K. (2015) Unchanged NADPH oxidase activity in Nox1-Nox2-Nox4 triple knockout mice: what do NADPH-stimulated chemiluminescence assays really detect? Antioxid. Redox Signal., doi:10.1089/ars.2015.6314
149. Rodrigues-Diez, R.R., Garcia-Redondo, A.B., Orejudo, M., Rodrigues-Diez, R., Briones, A.M., Bosch-Panadero, E., Kery, G., Pato, J., Ortiz, A., Salaices, M. et al. (2015) The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-kappaB pathway and proinflammatory factors in vascular smooth muscle cells. Antioxid. Redox Signal. 22, 29-47
150. Simossis, V.A. and Heringa, J. (2005) PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res. 33, W289-W294